Differential expression of histamine receptors in the bladder wall tissues of patients with bladder pain syndrome/interstitial cystitis - significance in the responsiveness to antihistamine treatment and disease symptoms.
Anti-histamine bladder
Bladder pain syndrome
Histamine receptors
Interstitial cystitis
Journal
BMC urology
ISSN: 1471-2490
Titre abrégé: BMC Urol
Pays: England
ID NLM: 100968571
Informations de publication
Date de publication:
12 Nov 2019
12 Nov 2019
Historique:
received:
09
08
2019
accepted:
31
10
2019
entrez:
14
11
2019
pubmed:
14
11
2019
medline:
19
3
2020
Statut:
epublish
Résumé
Activation of mast cells plays an important role in the pathogenesis of bladder pain syndrome/interstitial cystitis (BPS/IC). Histamine, a mast cell-derived mediators, induced inflammation and hypersensitivity of the bladder. The present study investigated the expressions of histamine receptors in the bladder wall tissues of patients with BPS/IC, and its association with the effectiveness of antihistamine therapy and disease symptoms. Bladder tissues were collected from 69 BPS/IC patients and 10 control female patients. The expression of H3R in BPS/IC was further examined in an independent cohort of 10 female patients with BPS/IC and another 10 age-matched female patients. Immunohistochemistry, Western blotting, and quantitative RT-PCR were performed to quantify the expressions of histamine receptors. Statistical analyses of the correlation of histamine receptor expression with antihistamine therapy outcome and severity of disease symptoms were also performed. The expression of four histamine receptors was significantly elevated in BPS/IC (H1R, P < 0.001; H2R, P = 0.031; H3R, P = 0.008; H4R, P = 0.048). Western blotting revealed that H3R were significantly reduced in the patients, whereas the mRNA levels of H3R were significantly increased. The patients were further divided into antihistamine responders (n = 38) and nonresponders (n = 22). No significant correlation was found in the expression of histamine receptors between responder and nonresponder groups. However, significant correlations between OLS and H1R (P = 0.003) and H3R (P = 0.045) were found. The present study showed that expression of all the 4 histamine receptors were elevated in BPS/IC. There were no statistical significant correlations between the expression levels of the four different histamine receptors and the treatment outcome of antihistamine therapy (amtitriptyline or cimetidine).
Sections du résumé
BACKGROUND
BACKGROUND
Activation of mast cells plays an important role in the pathogenesis of bladder pain syndrome/interstitial cystitis (BPS/IC). Histamine, a mast cell-derived mediators, induced inflammation and hypersensitivity of the bladder. The present study investigated the expressions of histamine receptors in the bladder wall tissues of patients with BPS/IC, and its association with the effectiveness of antihistamine therapy and disease symptoms.
METHODS
METHODS
Bladder tissues were collected from 69 BPS/IC patients and 10 control female patients. The expression of H3R in BPS/IC was further examined in an independent cohort of 10 female patients with BPS/IC and another 10 age-matched female patients. Immunohistochemistry, Western blotting, and quantitative RT-PCR were performed to quantify the expressions of histamine receptors. Statistical analyses of the correlation of histamine receptor expression with antihistamine therapy outcome and severity of disease symptoms were also performed.
RESULTS
RESULTS
The expression of four histamine receptors was significantly elevated in BPS/IC (H1R, P < 0.001; H2R, P = 0.031; H3R, P = 0.008; H4R, P = 0.048). Western blotting revealed that H3R were significantly reduced in the patients, whereas the mRNA levels of H3R were significantly increased. The patients were further divided into antihistamine responders (n = 38) and nonresponders (n = 22). No significant correlation was found in the expression of histamine receptors between responder and nonresponder groups. However, significant correlations between OLS and H1R (P = 0.003) and H3R (P = 0.045) were found.
CONCLUSION
CONCLUSIONS
The present study showed that expression of all the 4 histamine receptors were elevated in BPS/IC. There were no statistical significant correlations between the expression levels of the four different histamine receptors and the treatment outcome of antihistamine therapy (amtitriptyline or cimetidine).
Identifiants
pubmed: 31718622
doi: 10.1186/s12894-019-0548-3
pii: 10.1186/s12894-019-0548-3
pmc: PMC6852726
doi:
Substances chimiques
Histamine Antagonists
0
Receptors, Histamine
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
115Subventions
Organisme : Beijing Natural Science Foundation
ID : No. 7182058
Références
Clin Exp Allergy. 2007 Mar;37(3):308-10
pubmed: 17359380
Int Urol Nephrol. 2007;39(2):489-95
pubmed: 17431811
Pharmacol Biochem Behav. 2007 Nov;88(1):122-9
pubmed: 17719621
Urology. 1997 May;49(5A Suppl):58-63
pubmed: 9146003
J Allergy Clin Immunol. 2003 Jul;112(1):15-22
pubmed: 12847474
J Physiol. 2007 Sep 1;583(Pt 2):731-42
pubmed: 17627982
Urology. 2007 Apr;69(4 Suppl):34-40
pubmed: 17462477
Immunol Allergy Clin North Am. 2006 May;26(2):245-59, vii
pubmed: 16701143
Eur Urol. 2008 Jan;53(1):60-7
pubmed: 17900797
Curr Opin Urol. 2006 Jul;16(4):268-72
pubmed: 16770126
Nat Rev Drug Discov. 2008 Jan;7(1):41-53
pubmed: 18172439
Can J Urol. 2007 Aug;14(4):3599-607
pubmed: 17784979
Eur J Pharmacol. 2007 Jun 1;563(1-3):240-4
pubmed: 17382315
Urology. 2001 Jun;57(6 Suppl 1):47-55
pubmed: 11378050
Brain Res. 2009 Jan 23;1250:41-8
pubmed: 19046950
World J Urol. 2006 Jun;24(2):202-9
pubmed: 16609864
J Urol. 2005 Dec;174(6):2231-4
pubmed: 16280776
Expert Opin Pharmacother. 2008 Dec;9(17):2979-94
pubmed: 19006474
Urology. 2004 Jan;63(1):22-6
pubmed: 14751340